IPO - Nano Labs Ltd
Form Type: POS AM
Filing Date: 2025-04-25
Corporate Action: Ipo
Type: Update
Accession Number: 000121390025035246
Filing Summary: This Post-Effective Amendment No. 2 to the Registration Statement on Form F-1 for Nano Labs Ltd is to include updated information as required by the SEC, specifically reflecting details from the Company’s recently filed annual report on Form 20-F, which includes condensed consolidated financial statements for 2023 and 2024. No new securities are being registered under this amendment. The document highlights that all applicable registration fees were previously paid and outlines the structure of the Class A and Class B shares, including voting rights and conversion conditions. The document emphasizes that the company operates as a Cayman Islands holding company without direct operations in China, presenting unique risks and regulatory challenges. The potential impact of Chinese regulations on the company's operations and securities offerings is also discussed, alongside risks related to cash flow and regulatory compliance in this context. Furthermore, it affirms Nano Labs Ltd as an emerging growth company and indicates that the registration statement will become effective in due course, contingent on further amendments to be filed or as determined by the SEC.
Additional details:
Registration No: 333-278977
Emerging Growth Company: yes
Warrant Exercise Details: 652,174 Class A ordinary shares issuable upon the exercise of warrants by selling shareholders
Sale Price Class A: 4.9
Audit Firm: MaloneBailey, LLP
Audit Access Details: PCAOB has secured complete access to inspect firms in mainland China and Hong Kong.
Jar Milah Version: post-effective amendment no. 2
Comments
No comments yet. Be the first to comment!